Published in Am J Respir Crit Care Med on February 17, 2011
Endobronchial Mucosal Biopsy in Patients With Suspected Pulmonary Sarcoidosis | NCT04904939
Racial difference in sarcoidosis mortality in the United States. Chest (2015) 1.93
Who dies from sarcoidosis and why? Am J Respir Crit Care Med (2011) 1.42
Epidemiology of Sarcoidosis 1946-2013: A Population-Based Study. Mayo Clin Proc (2015) 0.97
Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study. BMC Pulm Med (2012) 0.95
Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. Am J Respir Crit Care Med (2014) 0.91
Mortality among African American women with sarcoidosis: data from the Black Women's Health Study. Sarcoidosis Vasc Diffuse Lung Dis (2013) 0.90
Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans. Genes Immun (2012) 0.90
Morbidity and mortality in sarcoidosis. Curr Opin Pulm Med (2014) 0.87
Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2013) 0.87
Sarcoidosis in the national veteran population: association of ocular inflammation and mortality. Ophthalmology (2015) 0.85
Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Am J Respir Crit Care Med (2014) 0.85
Sarcoidosis: sex-dependent variations in presentation and management. J Ophthalmol (2014) 0.84
Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis Protocol. Ann Am Thorac Soc (2015) 0.83
The clinical and immunologic features of pulmonary fibrosis in sarcoidosis. Transl Res (2012) 0.83
Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans. Am J Respir Cell Mol Biol (2015) 0.83
Replication of genetic loci for sarcoidosis in US black women: data from the Black Women's Health Study. Hum Genet (2013) 0.83
Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease. Cytokine (2013) 0.79
In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012. PLoS One (2016) 0.78
Uses, limitations, and complications of endobronchial ultrasound. Proc (Bayl Univ Med Cent) (2015) 0.78
Immune mediated diseases and immune modulation in the neurocritical care unit. Neurotherapeutics (2012) 0.78
The Etiologic Role of Infectious Antigens in Sarcoidosis Pathogenesis. Clin Chest Med (2015) 0.77
Fine-mapping in African-American women confirms the importance of the 10p12 locus to sarcoidosis. Genes Immun (2012) 0.77
Association Between Occupational Exposures and Sarcoidosis: An Analysis From Death Certificates in the United States, 1988-1999. Chest (2016) 0.77
A rare cause of severe lactic acidosis. BMJ Case Rep (2015) 0.75
Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry-The EXCITING-ILD Registry. Biomed Res Int (2015) 0.75
Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated with Rituximab and Mycophenolate Mofetil. Case Rep Hematol (2016) 0.75
Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases. PLoS Genet (2015) 0.75
The high frequency of healthcare use in patients one year prior to a sarcoidosis diagnosis. Sarcoidosis Vasc Diffuse Lung Dis (2014) 0.75
New molecular targets for the treatment of sarcoidosis. Curr Opin Pulm Med (2016) 0.75
Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis. J Transl Med (2016) 0.75
Reliability of Cardiovascular Risk Calculators to Estimate Accurately the Risk of Cardiovascular Disease in Patients With Sarcoidosis. Am J Cardiol (2017) 0.75
Sarcoidosis. N Engl J Med (2007) 14.92
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol (1997) 5.00
Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med (2010) 3.05
Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med (2007) 2.66
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax (2006) 2.59
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 2.20
Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. Am J Med (1996) 2.04
Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis (1984) 2.02
A comparison of underlying cause and multiple causes of death: US vital statistics, 2000-2001. Epidemiology (2006) 1.57
Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med (1995) 1.55
Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med (1983) 1.46
Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect (1998) 1.42
Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest (2010) 1.31
The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis (1995) 1.27
Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest (2001) 1.19
The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis. J Clin Epidemiol (1993) 1.04
Evidence for association between sarcoidosis and pulmonary embolism from 35-year record linkage study. Thorax (2010) 1.03
Aging, antagonistic pleiotropy and fibrotic disease. Int J Biochem Cell Biol (2010) 1.01
The age of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 0.95
Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis (2000) 0.92
Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis (1989) 0.90
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med (2014) 10.62
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med (2011) 6.74
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med (2011) 6.40
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med (2004) 6.02
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med (2012) 5.37
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med (2012) 5.33
Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med (2005) 4.25
The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med (2005) 4.25
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med (2005) 4.15
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med (2008) 3.97
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2003) 3.89
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med (2011) 3.85
Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest (2006) 3.59
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 3.49
Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med (2006) 3.32
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 3.23
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet (2013) 3.17
Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med (2010) 3.05
Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med (2003) 3.00
Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol (2013) 2.74
Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med (2007) 2.66
Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med (2008) 2.65
Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest (2010) 2.51
Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med (2003) 2.50
Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol (2002) 2.43
Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med (2004) 2.42
Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med (2006) 2.34
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA (2013) 2.20
Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest (2002) 2.19
The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med (2009) 2.18
Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest (2004) 2.00
High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med (2005) 1.90
Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007. Chest (2011) 1.85
A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes. Respirology (2010) 1.80
The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. PLoS One (2013) 1.78
Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. Thorax (2013) 1.77
Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest (2006) 1.76
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. Lancet Respir Med (2013) 1.69
Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter. Chest (2008) 1.65
Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. Chest (2005) 1.60
Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). PLoS One (2009) 1.56
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med (2014) 1.54
Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest (2007) 1.53
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest (2010) 1.52
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med (2013) 1.51
Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol (2007) 1.51
Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest (2009) 1.50
Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol (2004) 1.50
Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease. Chest (2006) 1.48
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax (2009) 1.46
Open-access biorepository for idiopathic pulmonary fibrosis. The way forward. Ann Am Thorac Soc (2014) 1.42
Rheumatoid arthritis-related lung diseases: CT findings. Radiology (2004) 1.40
A 25-year-old woman with diffuse abdominal pain and shock. Chest (2009) 1.39
Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol (2011) 1.38
Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med (2009) 1.36
Amygdala regulation of immediate-early gene expression in the hippocampus induced by contextual fear conditioning. J Neurosci (2006) 1.35
The role of dorsal hippocampus and basolateral amygdala NMDA receptors in the acquisition and retrieval of context and contextual fear memories. Behav Neurosci (2007) 1.34
Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA. Clin Rheumatol (2009) 1.32
Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respirology (2011) 1.32
Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med (2005) 1.30
Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology (2008) 1.29
Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest (2007) 1.28
Predicting pulmonary fibrosis disease course from past trends in pulmonary function. Chest (2014) 1.25
Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest (2004) 1.24
Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med (2012) 1.23
The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med (2004) 1.22
Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr (2002) 1.20
Radiologic and pathologic features of bronchiolitis. AJR Am J Roentgenol (2005) 1.20
Nonspecific interstitial pneumonia: radiologic, clinical, and pathologic considerations. Radiographics (2009) 1.18
TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis. Am J Respir Cell Mol Biol (2005) 1.17
Rare variants in RTEL1 are associated with familial interstitial pneumonia. Am J Respir Crit Care Med (2015) 1.15
Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials. Clin Exp Rheumatol (2010) 1.15
Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med (2005) 1.13
Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest (2013) 1.11
The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. PLoS One (2012) 1.07
Human lung project: evaluating variance of gene expression in the human lung. Am J Respir Cell Mol Biol (2006) 1.07
Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis. Ann Intern Med (2013) 1.07
Challenges in pulmonary fibrosis. 3: Cystic lung disease. Thorax (2007) 1.05
Scleroderma lung disease. Eur Respir Rev (2013) 1.04